FDA Debates Breast Cancer Drug’s Fate

The best-selling cancer drug in the world comes under federal scrutiny once again this week, as drugmaker Roche makes a last-ditch effort to keep Avastin approved for breast cancer. (June 28)

View original post here:
FDA Debates Breast Cancer Drug’s Fate

Posted by on June 28, 2011. Filed under News, Video. You can follow any responses to this entry through the RSS 2.0. You can skip to the end and leave a response. Pinging is currently not allowed.